Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China
· Delayed Price · Currency is CNY 46.69
+0.17 (0.37%)
At close: Dec 5, 2025
SHA:603392 Market Cap
SHA:603392 has a market cap or net worth of 59.07 billion as of December 5, 2025. Its market cap has decreased by -37.75% in one year.
Market Cap
59.07B
Enterprise Value
54.50B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.69
Market Cap Chart
Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 59.07B, an increase of 981.18%. That is a compound annual growth rate of 52.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 59.07B | -33.74% |
| Dec 31, 2024 | 89.14B | -6.44% |
| Dec 29, 2023 | 95.28B | -17.00% |
| Dec 30, 2022 | 114.80B | -14.62% |
| Dec 31, 2021 | 134.46B | 53.87% |
| Dec 31, 2020 | 87.38B | 1,499.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 409.56B |
| WuXi AppTec | 269.53B |
| Shenzhen Mindray Bio-Medical Electronics | 244.77B |
| Sichuan Biokin Pharmaceutical | 150.27B |
| Shanghai United Imaging Healthcare | 107.10B |
| Aier Eye Hospital Group | 105.04B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.93B |
| Yunnan Baiyao Group Co.,Ltd | 99.79B |